The evidence available from the present study showed that ECC improved cognitive function in experimental AD mainly through mechanisms involving antioxidant stress and antiapoptosic effects, inhibiting Aβ deposition and tau protein hyperphosphorylation and promoting synapse protection. This evidence concerns the gene MAPT and Alzheimer disease.